A Comprehensive Overview of the Therapeutic Potential of Pyrimidine Analogues in the Management of Colorectal Cancer

Area of Science:

• Medicinal Chemistry
• Oncology

Background:

• Colorectal cancer is a leading cause of cancer death globally.
• Pyrimidine is crucial for DNA/RNA, making it a key target in cancer therapy.
• Pyrimidine analogues are being explored for their anti-cancer properties.

Purpose of the Study:

• To review the synthesis and anti-cancer potential of pyrimidine derivatives.
• To assess the efficacy of pyrimidine analogues against cancer cell lines.
• To explore structure-activity relationships for enhanced anti-cancer efficacy.

Main Methods:

• Review of recent research on pyrimidine derivative synthesis and assessment.
• Evaluation of preclinical data for pyrimidine analogues against cancer models.
• Analysis of structure-activity relationships (SAR) for pyrimidine compounds.

Main Results:

• Several pyrimidine-based chemical families (e.g., 1H-pyrazolo, diarylpyrazolo, bromo-pyrimidine) exhibit potent anti-cancer activity in preclinical models.
• These derivatives show particular efficacy against lung and colon cancer cell lines.
• SAR studies indicate that modifications to the pyrimidine scaffold enhance anti-cancer properties.

Conclusions:

• Pyrimidine analogues represent a promising class of compounds for cancer therapy.
• Further investigation into pyrimidine derivatives is warranted for developing novel colon cancer treatments.
• Targeting pyrimidine-related pathways offers a viable strategy for anti-cancer drug development.